🇺🇸 FDA
Patent

US 11555055

Peptide inhibitors of insulin-degrading enzyme

granted A61KA61K2800/91A61K2800/92

Quick answer

US patent 11555055 (Peptide inhibitors of insulin-degrading enzyme) held by The Regents of the University of California expires Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K2800/91, A61K2800/92, A61K38/00, A61K38/08